KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Supernus Pharmaceuticals (SUPN) over the last 6 years, with Q3 2025 value amounting to $397543.0.

  • Supernus Pharmaceuticals' Treasury Shares fell 142.75% to $397543.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $397543.0, marking a year-over-year decrease of 142.75%. This contributed to the annual value of $378165.0 for FY2024, which is 2599.58% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Treasury Shares stood at $397543.0 for Q3 2025, which was down 142.75% from $439216.0 recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Treasury Shares registered a high of $439216.0 during Q2 2025, and its lowest value of $89125.0 during Q3 2021.
  • Moreover, its 5-year median value for Treasury Shares was $306516.0 (2023), whereas its average is $279131.6.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 24206.49% in 2021, then crashed by 142.75% in 2025.
  • Supernus Pharmaceuticals' Treasury Shares (Quarter) stood at $89125.0 in 2021, then skyrocketed by 126.37% to $201750.0 in 2022, then skyrocketed by 48.77% to $300141.0 in 2023, then increased by 26.0% to $378165.0 in 2024, then grew by 5.12% to $397543.0 in 2025.
  • Its last three reported values are $397543.0 in Q3 2025, $439216.0 for Q2 2025, and $407867.0 during Q1 2025.